Investor Deck · 2026
Rebuilding Cognitive Resilience for Women.
A new category in women’s cognitive wellness.
Press & hold to open
Confidential
Enter the passphrase you were given to view the Blyssminds investor deck.
That passphrase doesn’t match. Try again.
Investor Deck · 2026
A new category in women’s cognitive wellness.
The story
“There was no safe option. So I built one.”
I grew up watching my mother cycle through misdiagnoses for years — treated for the wrong conditions, put on a pharmaceutical later recalled for worsening symptoms. I learned early that when we get women’s mental health wrong, the cost is real.
When I was diagnosed with ADHD as an adult after years of misdiagnosis, I finally found something that worked. Then I became pregnant and had to stop everything. No safe alternatives existed.
I struggled through pregnancy and postpartum completely unsupported — and I realized this wasn’t just my story. It’s happening to millions of women, and they deserve better. Blyssminds is the solution I needed. I’m building it for every woman who still does.
— Alyssa Mack-Lee
The problem
Not safe during hormonal stages like pregnancy and postpartum.
Not designed for maternal cognitive needs; mostly built for men’s biology.
Important, but don’t address the nutritional gap.
Also underserved: neurodivergent women (ADHD, perimenopause) — a growing secondary market with zero pregnancy-safe options today.
Our solution
Daytime focus, energy, and mental clarity — a clinically-informed scoop that tastes like dessert.
A calmer wind-down through the gut-brain axis, supporting rest and recovery.
Science & ingredients




All ingredients selected for pregnancy & lactation safety within Health Canada’s NHP regulatory framework.
Market opportunity
The gap no one has filled
| Pharma | Olly | Ritual | Generic | Blyssminds | |
|---|---|---|---|---|---|
| Clinically validated | — | – | ingredient studies | – | QEEG pilot, signed LOIs |
| Women-specific formula | – | women’s line, not neuro | women’s health, not cognition | – | Cognitive + maternal |
| Practitioner-led channel | prescription model | mass retail only | DTC only | – | Trust built into the channel |
| Serves neurodivergent women | Rx only | – | – | – | ADHD, postpartum, perimenopause |
| Subscription model | – | retail-limited | sub & save | Amazon sub | 3 & 6-month plans |
Why practitioner-led wins
The practitioner math
Pregnant, postpartum and neurodivergent patients who can’t take pharmaceuticals are left with nothing. Blyssminds fills that gap.
Referrals arrive warm and high-intent. Conversion is higher, churn is lower, no paid ads needed.
Evidence-informed, NPN approved, pregnancy safe. Practitioners can recommend it with confidence.
Early partners shape the product — creating loyalty and long-term advocacy.
Go-to-market strategy
Warm referral → 30-day ritual → 3 or 6-month subscription. US expansion via Adventure CPG. CHFA Toronto, Sept 2026.
EluMind QEEG pilot — 60 women, 6 months, 3 scans, double-blind placebo-controlled. REB submission in progress. The proof point that opens every door.
Midwives, naturopaths, clinical counsellors, doulas & dietitians — approached with clinical data and confidence.
Proof of model — signed LOI
Strength Counselling Services (March 2026) — a multidisciplinary Canadian mental-health practice committed to clinical evaluation, practitioner trialing, and recommending Blyssminds to clients navigating ADHD, postpartum, burnout & cognitive load.
Traction & momentum
Natural Products Canada — ecosystem acceptance
Accepted into the NPC ecosystem. Working with the BC Regional Director on a $350K Proof-of-Concept grant (non-dilutive) — validating commercial readiness and de-risking the raise for investors.
Our give-back mission
A portion of every Blyssminds sale supports access to mental-health care for Canadians who need it most.
Blyssminds is a wellness brand. Clinical services are provided independently by partner organizations.
Meet the team

Founder & CEO

Scientific Advisor · R&D, Product & Development

Microbiologist · Food Safety & Regulatory Advisor
Community & Operations Manager
Planned hires — funded by this raise
Funding needs & milestones
Pilot design, recruitment, QEEG coordination, data & biomarker analysis.
Manufacturing scale-up, packaging, quality assurance, production readiness.
Practitioner education, scientific materials, DTC infrastructure, early acquisition.
IP strategy, brand protection, formulation expansion, category positioning.
12–18 month milestones
Commercial launch · EluMind pilot underway · Practitioner + DTC channels live · IP strengthened · Initial revenue & traction.
The ask
$750,000
We’re at the earliest and most valuable entry point. The foundation is built. Now we need the fuel.
“Your Brain, Your Blyss. Wellness that gives back.”
info@blyssminds.com · blyssminds.com · +1 (604) 991-5487 · @blyssmindshealth